Abridge Expands to 80M+ Conversations and $5.3B Valuation in 2025
Deploy Abridge's ambient documentation pipeline to reduce clinician EHR burden.
Deploy Abridge's ambient documentation pipeline to reduce clinician EHR burden.
Summary
Founded in 2018, Abridge has built a clinical documentation platform that listens to patient‑clinician conversations, generates notes, and reduces clerical burden.
The company now projects 80 million+ patient‑clinician conversations this year across 250 large U.S. health systems, supporting 28+ languages and 50+ specialties. Abridge raised $300 million in a Series E round at a $5.3 billion valuation in June 2025, following a $250 million Series D earlier that year. The product focuses on ambient documentation, clinical decision support, prior authorization, and real‑time agents that act before, during, and after patient visits. Abridge’s data pipeline integrates with EHRs, handles de‑identification, and uses clinician‑verified outputs to reduce downstream friction in billing and quality metrics. The company’s roadmap expands from ambient scribe to a full clinical intelligence layer, aiming to save time, money, and lives for clinicians and payers alike.
Key changes
- Founded 2018, focused on clinical documentation
- 80 M+ conversations projected this year
- 250 large U.S. health systems, 28+ languages, 50+ specialties
- $300 M Series E at $5.3 B valuation (June 2025)
- $250 M Series D earlier 2025
- Ambient documentation, clinical decision support, prior authorization, real‑time agents
- EHR integration, de‑identification, clinician‑verified outputs